Quellen:
[1] “Effect of low-dose oral contraceptive on gonadotropins, androgens, and sex hormone binding globulin in nonhirsute women,” PubMed, Jan. 01, 1990. Available: https://pubmed.ncbi.nlm.nih.gov/2136834/
[2] Y. Zimmerman, E. Mj, C. B. Hj, M. A. Blankenstein, and F. Bc, “The effect of combined oral contraception on testosterone levels in healthy women: a systematic review and meta-analysis,” Human Reproduction Update, vol. 20, no. 1, pp. 76–105, Sep. 2013, doi: 10.1093/humupd/dmt038. Available: https://pubmed.ncbi.nlm.nih.gov/24082040/
[3] M. Raps et al., “Sex hormone‐binding globulin as a marker for the thrombotic risk of hormonal contraceptives,” Journal of Thrombosis and Haemostasis, vol. 10, no. 6, pp. 992–997, Jun. 2012, doi: 10.1111/j.1538-7836.2012.04720.x. Available: https://pubmed.ncbi.nlm.nih.gov/22469296/
[4] R. Stricker, R. Eberhart, M.-C. Chevailler, F. A. Quinn, P. Bischof, and R. Stricker, “Establishment of detailed reference values for luteinizing hormone, follicle stimulating hormone, estradiol, and progesterone during different phases of the menstrual cycle on the Abbott ARCHITECT® analyzer,” Clinical Chemistry and Laboratory Medicine, vol. 44, no. 7, Jan. 2006, doi: 10.1515/cclm.2006.160. Available: https://pubmed.ncbi.nlm.nih.gov/16776638/
[5] D. R. Mishell, I. H. Thorneycroft, R. M. Nakamura, Y. Nagata, and S. Stone, “Serum estradiol in women ingesting combination oral contraceptive steroids,” American Journal of Obstetrics and Gynecology, vol. 114, no. 7, pp. 923–928, Dec. 1972, doi: 10.1016/0002-9378(72)90098-1. Available: https://pubmed.ncbi.nlm.nih.gov/4645131/
[6] P. D. Darney, R. N. Taylor, C. Klaisle, K. Bottles, and C. Zaloudek, “Serum concentrations of estradiol, progesterone, and levonorgestrel are not determinants of endometrial histology or abnormal bleeding in long-term Norplant® implant users,” Contraception, vol. 53, no. 2, pp. 97–100, Feb. 1996, doi: 10.1016/0010-7824(95)00266-9. Available: https://pubmed.ncbi.nlm.nih.gov/8838486/
[7] “Acute effect of alcohol on estradiol, estrone, progesterone, prolactin, cortisol, and luteinizing hormone in premenopausal women,” PubMed, Jun. 01, 1999. Available: https://pubmed.ncbi.nlm.nih.gov/10397281/
[8] P. D. Darney, R. N. Taylor, C. Klaisle, K. Bottles, and C. Zaloudek, “Serum concentrations of estradiol, progesterone, and levonorgestrel are not determinants of endometrial histology or abnormal bleeding in long-term Norplant® implant users,” Contraception, vol. 53, no. 2, pp. 97–100, Feb. 1996, doi: 10.1016/0010-7824(95)00266-9. Available: https://pubmed.ncbi.nlm.nih.gov/8838486/
[9] C. J. Sørensen et al., “Combined Oral Contraception and Obesity Are Strong Predictors of Low-Grade Inflammation in Healthy Individuals: Results from the Danish Blood Donor Study (DBDS),” PloS One, vol. 9, no. 2, p. e88196, Feb. 2014, doi: 10.1371/journal.pone.0088196. Available: https://pubmed.ncbi.nlm.nih.gov/24516611/
[10] S. Cauci, M. P. Francescato, and F. Curcio, “Combined oral contraceptives increase High-Sensitivity C-Reactive protein but not haptoglobin in female athletes,” Sports Medicine, vol. 47, no. 1, pp. 175–185, Apr. 2016, doi: 10.1007/s40279-016-0534-9. Available: https://pubmed.ncbi.nlm.nih.gov/27084393/
[11] J. O. McArthur, H. Tang, P. Petocz, and S. Samman, “Biological variability and impact of oral contraceptives on vitamins B6, B12 and folate status in women of reproductive age,” Nutrients, vol. 5, no. 9, pp. 3634–3645, Sep. 2013, doi: 10.3390/nu5093634. Available: https://pubmed.ncbi.nlm.nih.gov/24067390/
[12] A. B. Berenson and M. Rahman, “Effect of hormonal contraceptives on vitamin B12 level and the association of the latter with bone mineral density,” Contraception, vol. 86, no. 5, pp. 481–487, Nov. 2012, doi: 10.1016/j.contraception.2012.02.015. Available: https://pubmed.ncbi.nlm.nih.gov/22464408/
[13] A. B. Berenson, M. Rahman, and G. S. Wilkinson, “Effect of injectable and oral contraceptives on serum lipids,” Obstetrics and Gynecology (New York. 1953. Online)/Obstetrics and Gynecology, vol. 114, no. 4, pp. 786–794, Oct. 2009, doi: 10.1097/aog.0b013e3181b76bea. Available: https://pubmed.ncbi.nlm.nih.gov/19888036/
[14] T. Piltonen et al., “Oral, transdermal and vaginal combined contraceptives induce an increase in markers of chronic inflammation and impair insulin sensitivity in young healthy normal-weight women: a randomized study,” Human Reproduction, vol. 27, no. 10, pp. 3046–3056, Jul. 2012, doi: 10.1093/humrep/des225. Available: https://pubmed.ncbi.nlm.nih.gov/22811306/
[15] G. S. Merki‐Feld, B. Imthurn, M. Rosselli, and K. Spanaus, “Implanon use lowers plasma concentrations of high-molecular-weight adiponectin,” Fertility and Sterility, vol. 95, no. 1, pp. 23–27, Jan. 2011, doi: 10.1016/j.fertnstert.2010.05.018. Available: https://pubmed.ncbi.nlm.nih.gov/20576266/